Abstract

BackgroundHuman endothelial nitric oxide synthase (eNOS) requires calcium-bound calmodulin (CaM) for electron transfer but the detailed mechanism remains unclear.Methodology/Principal FindingsUsing a series of CaM mutants with E to Q substitution at the four calcium-binding sites, we found that single mutation at any calcium-binding site (B1Q, B2Q, B3Q and B4Q) resulted in ∼2–3 fold increase in the CaM concentration necessary for half-maximal activation (EC50) of citrulline formation, indicating that each calcium-binding site of CaM contributed to the association between CaM and eNOS. Citrulline formation and cytochrome c reduction assays revealed that in comparison with nNOS or iNOS, eNOS was less stringent in the requirement of calcium binding to each of four calcium-binding sites. However, lobe-specific disruption with double mutations in calcium-binding sites either at N- (B12Q) or at C-terminal (B34Q) lobes greatly diminished both eNOS oxygenase and reductase activities. Gel mobility shift assay and flavin fluorescence measurement indicated that N- and C-lobes of CaM played distinct roles in regulating eNOS catalysis; the C-terminal EF-hands in its calcium-bound form was responsible for the binding of canonical CaM-binding domain, while N-terminal EF-hands in its calcium-bound form controlled the movement of FMN domain. Limited proteolysis studies further demonstrated that B12Q and B34Q induced different conformational change in eNOS.ConclusionsOur results clearly demonstrate that CaM controls eNOS electron transfer primarily through its lobe-specific calcium binding.

Highlights

  • Human endothelial nitric oxide synthase catalyzes the synthesis of nitric oxide (NNO), which is a key regulator of cardiovascular homeostasis [1,2]

  • Quantitative analysis from multiple experiments revealed that the EC50 for the single-site mutants is about 2–3 fold higher than that of wild-type (Table 2)

  • These data suggest that each of the four calcium-binding sites supports the association between CaM and endothelial nitric oxide synthase (eNOS) (Table 2)

Read more

Summary

Introduction

Human endothelial nitric oxide synthase (eNOS) catalyzes the synthesis of nitric oxide (NNO), which is a key regulator of cardiovascular homeostasis [1,2]. The reductase domain binds FAD and FMN cofactors, and consists of NADPH binding site, while the oxygenase domain binds protoporphrin IX heme, tetrahydrobiopterin (H4B), and contains the site for L-arginine binding. These two domains are connected by a canonical CaM-binding sequence. The mechanism by which CaM regulates NOS activation has been under intensive investigation, much remains unresolved. Human endothelial nitric oxide synthase (eNOS) requires calcium-bound calmodulin (CaM) for electron transfer but the detailed mechanism remains unclear

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.